As Expected, Affy Restates Earnings, Clearing Nasdaq Noncompliance and Investor Default | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix today said it has restated its unreliable financial results and filed them with the Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.